Psychedelic-Assisted Psychotherapy - Pharmacologic, Psychotherapeutic, and Practical Considerations

Speakers: Dr. Randy Buzan and Dr. Susan Frederick
CE credits offered: 1
Program Level: Intermediate

We will discuss the pharmacology of psychedelics, patient selection for psychedelic-assisted psychotherapy (PAP), and preparation, procedure, and process of PAP. The importance of integration work will also be discussed.

Learning Objectives:

  1. Discuss Screening criteria for patients for PAP and considerations when choosing a patient-appropriate medicine
  2. Describe the role of the facilitator/guide in a PAP session
  3. Explain the critical importance of good preparation for and integration of PAP work

About Dr. Randy Buzan and Dr. Susan Frederick

Randall Buzan completed his psychiatry residency at the University of Colorado, graduated from the PTP program at the Denver Institute for Psychoanalysis and then completed his psychoanalytic training at the DIP. He completed a fellowship in psychopharmacology at the University of Colorado and another mini-fellowship in electroconvulsive therapy at Duke. While on the medical school psychiatry faculty he directed the ECT service, ran the psychiatry department’s outpatient services, and did psychopharmacology and neuropsychiatry research. Randy has published more than 25 papers and book chapters and has been the chief neuropsychiatric consultant at Craig Hospital for the past 30 years. More recently he graduated from the Psychedelic-Assisted Psychotherapy Program of the Integrative Psychiatry Institute in 2022, and the Ketamine-Assisted Psychotherapy program through PRATI in 2022. He has also completed the MAPS MDMA online training component.

Susan Frederick completed her Adult Psychiatry residency at the University of Colorado Health Sciences Center as well as her Child and Adolescent Psychiatry fellowship. She did her Adult, Adolescent, and Child Psychoanalytic training at Denver Institute for Psychoanalysis. She is a Distinguished Fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry. She graduated from the Psychedelic-Assisted Psychotherapy Program of the Integrative Psychiatry Institute in 2022, the Ketamine Assisted Psychotherapy Program through PRATI in 2022, the Trauma Touch Therapy Program at the Colorado School of the Healing Arts in 2022, and the Ketamine and Psychedelic Assisted Psychotherapy at the End of Life Program through PRATI in 2023. She has also completed the MAPS MDMA online training component.

 

Return to Agenda